Ads
related to: treatment of malaria in africa journal research
Search results
Results From The WOW.Com Content Network
Research in Africa found a one-time dose of an experimental drug protected adults against malaria for at least six months, the latest approach in the fight against the mosquito-borne disease.
The recommendation applies only for areas with high malaria transmission and low resistance against SP, both measures are not free of controversy and only available for few spots in Africa. With the recent drop of malaria transmission in wide stretches of Africa [30] [31] and a steady increase in SP resistance [32] [33] few malaria control ...
HIV testing and treatment with the use of a community health approach in rural Africa. [5] Predictors of long-term viral failure among Ugandan children and adults treated with antiretroviral therapy. [6] Malaria in Uganda: challenges to control on the long road to elimination: I. Epidemiology and current control efforts. [7]
The major commercial manufacturer of mefloquine-based malaria treatment is Roche Pharmaceuticals, which markets the drug under the trade name Lariam. Lariam is fairly expensive at around three € per tablet (pricing of the year 2000). A dose of 15–25 mg/kg is recommended, depending on the prevalence of mefloquine resistance.
The Malaria Journal is a peer-reviewed open access medical journal published by BioMed Central. It was established in 2002 [ 1 ] and covers research on malaria and related topics. The editor-in-chief is Marcel Hommel ( University of Liverpool ).
In sub-Saharan Africa, for example, where USAID oversees services including HIV prevention and treatment, girls and women ages 15 to 24 are three times more likely to contract the virus than boys ...
Greenwood's career has focused on mitigating the effects of malaria and pertinent research. [1] In his ten years experience working in Nigeria, and his fifteen years as the head of the Medical Research Council Laboratories in the Gambia, his main research interests were malaria and infections caused by capsulated bacteria such as the meningococcus (Neissera meningitidis).
Research remains an important aspect of Malaria Consortium's strategy and the organization publishes research in open access and scholarly journals. For instance, it worked with Cambodian National Center for Parasitology, Entomology and Malaria Control and WHO, contributing on research regarding the use of Guppy Fishes as part of an integrated ...